Sunday, October 23, 2016 4:13:05 PM
Vantage mHealthcare Announces Banking Agreement with China Merchants Bank
August 18, 2015 08:30 AM Eastern Daylight Time
NEW YORK--(BUSINESS WIRE)--Vantage mHealthcare, Inc. (OTCQB:VNTH) (“Vantage Health” or the “Company”) today announced that Nanobeak LLC, its parent company, has engaged China Merchants Bank New York for a private placement of $20 million in equity for the Company exclusively for China.
“We have been searching for the right investment banking partner in Asia and China Merchants Bank fits well with our strategy in executing our business plan. They have a highly regarded reputation and we are excited to be the beneficiary of their vast experience throughout China.”
Tweet this
Headquartered in China, China Merchants Bank Co., Ltd. is a leading commercial bank for corporate/investment banking and personal banking. With total assets of US $764 billion and a ROE of 19% at yearend 2014, China Merchants Bank was awarded the “Best Bank in China” by the Global Finance of the United States in their selection of the “Best Banks in Emerging Markets”. China Merchants Bank is presently the 6th largest bank in China.
Upon closing, this $20 million equity round will be used to fund expanded laboratory facilities in Mountain View, California, recruit additional scientific staff, fund clinical trials and subsequent regulatory approval. The prospective equity partner from China will also help the Company to develop strategic partnerships in China, the largest healthcare market in the world, for distribution and sales of the Nanobeak technology once development is concluded and regulatory approvals have been met.
Mr. Chengyue Jiao, General Manager of China Merchants Bank New York Branch commented, “We are excited to work with a US medical device company dedicated to providing a revolutionary product for early stage cancer detection. With its success, it will benefit patients and consumers in China tremendously, and help to reduce death rates and create social benefits. We are delighted the Company chose to work with China Merchants Bank as its exclusive transaction adviser for China, and to leverage our extensive client relationships there to capture the capital and investment interest to support one of the world’s largest healthcare markets.”
Mr. Joseph Peters, President of Vantage mHealthcare said, “We have been searching for the right investment banking partner in Asia and China Merchants Bank fits well with our strategy in executing our business plan. They have a highly regarded reputation and we are excited to be the beneficiary of their vast experience throughout China.”
On Monday, August 24, 2015, Vantage mHealthcare, Inc. will officially change its name to Nano Mobile Healthcare, Inc.
About Vantage mHealthcare Inc.
Vantage mHealthcare - a mobile health technology company - is developing personalized and point-of-care screening using Apps based upon chemical sensing residing within a Bluetooth device that works with any smartphone, tablet or laptop. With its foundations in advanced nanotechnology, the Company’s first product, the Vantage Health Sensor, which is in development, is the convergence of nano-electronics, bio-informatics, and wireless technology to create the next generation mobile health application.
The Company has offices in New York City and Mountain View, CA. For more information, please visit http://www.Vantagemhealthcare.com.
About China Merchants Bank
Established in 1987 in Shenzhen, the forefront of China’s reform and opening-up drive, China Merchants Bank ("CMB") is China’s first joint-stock commercial bank and also the first bank to attend the national experiment for the promotion of China’s banking industry reform driven by endeavors from outside the government.
Since its inception 24 years ago, CMB has grown with China’s economic progress into a nationwide joint-stock commercial bank that has total net capital of 140 billion yuan, total assets of 2.6 trillion yuan, over 800 branches and over 50,000 employees, ranking it among the world’s top 100 banks. CMB has developed into one of the most influential commercial bank brands in China thanks to continuous financial innovation, quality customer service, prudent management and strong business performance. For many consecutive years, CMB has been ranked among China’s top commercial banks according to comprehensive assessments by China Banking Regulatory Commission (CBRC).
VANTAGE MHEALTHCARE, INC.
OTCQB:VNTH View stock quote and chart View SEC Filings
Release Summary
Vantage mHealthcare Announces Banking Agreement with China Merchants Bank for a $20 million private placement with Nanobeak LLC, its parent company, exclusively for China.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM